U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

The FDA Drug Shortage database is currently experiencing technical difficulties and some of the information contained in the database may not reflect the current supply status.

Start Over | Back to Previous Screen

Gentamicin Sulfate Injection
Status: Currently in Shortage
»Date first posted: 07/23/2021
»Therapeutic Categories: Anti-Infective

Expand all

Baxter (New 07/26/2022)

Company Contact Information:
888-229-0001

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Gentamicin Sulfate in 0.9% Sodium Chloride Injection, 60 mg/50 mL, (NDC 0338-0507-41) Available

Baxter (New 07/26/2022)

Company Contact Information:
888-229-0001

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Gentamicin Sulfate in 0.9% Sodium Chloride Injection, 80 mg/50 mL, (NDC 0338-0509-41) Available
Gentamicin Sulfate in 0.9% Sodium Chloride Injection, 80mg/100 mL, (NDC 0338-0503-48) Available
Gentamicin Sulfate in 0.9% Sodium Chloride Injection, 100 mg/50 mL, (NDC 0338-0511-41) Available
Gentamicin Sulfate in 0.9% Sodium Chloride Injection, 100 mg/100 mL, (NDC 0338-0505-48) Available
Gentamicin Sulfate in 0.9% Sodium Chloride Injection, 120 mg/100 mL, (NDC 0338-0507-48) Available

Fresenius Kabi USA, LLC (Revised 08/12/2022)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
80 mg per 2 mL (40 mg per mL), MDV, (NDC 63323-010-02) Backordered. Next release October 2022. Demand increase for the drug
800 mg per 20 mL (40 mg per mL), MDV, (NDC 63323-010-20) Backordered. Next release August 2022. Demand increase for the drug
20 mg per 2 mL (10 mg per mL), Pediatric SDV, (NDC 63323-173-02) Backordered. Next release August 2022. Demand increase for the drug

Hospira, Inc. (Revised 08/12/2022)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
80 mg/2 mL (40 mg/mL); 2 mL Single Dose Glass Fliptop Vial (NDC 00409-1207-03) Next Delivery and Estimated Recovery: January 2023 Manufacturing delay
80 mg/2 mL (40 mg/mL) Single Dose Glass Fliptop Vial NovaPlus (NDC 00409-1207-25) Next Delivery and Estimated Recovery: January 2023 Manufacturing delay
Back to Top